In our last Letter from the Editor, we incorrectly reported the name of Schering's Primovist MRI contrast agent in our story about European Union approval of the product.
Correction
Oct 4, 2004
Latest in Clinical News
Theranostic pair ready for testing in lung cancer
January 8, 2026
BrightHeart closes on $12.8M funding round
January 8, 2026
Siemens Healthineers gets FDA nod for Magnetom Flow
January 8, 2026
















